Evidence map›Paper›PMID 27390361›Full record

ArticleHaematologica2016

Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.

Yahya S Al-Matary, Lacramioara Botezatu, Bertram Opalka, Judith M Hönes, Robert F Lams, Aniththa Thivakaran, Judith Schütte, Renata Köster, Klaus Lennartz, Thomas Schroeder and 3 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Current status and challenges of TCR-T cell therapy for AML/MDS.International journal of hematology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. CAR-T cell therapy for cancer: current challenges and future directions.Signal transduction and targeted therapy · 2025
    Review
  19. Review
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yahya S Al-MataryDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Lacramioara BotezatuDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Bertram OpalkaDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Judith M HönesDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Robert F LamsDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Aniththa ThivakaranDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Judith SchütteDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Renata KösterDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Klaus LennartzInstitute of cell biology (Tumor Research), University Hospital Essen, University of Duisburg-Essen.
Thomas SchroederDepartment of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, University Hospital, Germany.
Rainer HaasDepartment of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, University Hospital, Germany.
Ulrich DührsenDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ).
Cyrus KhandanpourDepartment of Hematology, University Hospital of Essen, West German Cancer Center (WTZ) cyrus.khandanpour@uk-essen.de.
Düsseldorf University Hospital · DEHeinrich Heine University Düsseldorf · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growth of malignant cells is not only driven by cell-intrinsic factors, but also by the surrounding stroma. Monocytes/Macrophages play an important role in the onset and progression of solid cancers. However, little is known about their role in the development of acute myeloid leukemia, a malignant disease characterized by an aberrant development of the myeloid compartment of the hematopoietic system. It is also unclear which factors are responsible for changing the status of macrophage polarization, thus supporting the growth of malignant cells instead of inhibiting it. We report herein that acute myeloid leukemia leads to the invasion of acute myeloid leukemia-associated macrophages into the bone marrow and spleen of leukemic patients and mice. In different leukemic mouse models, these macrophages support the in vitro expansion of acute myeloid leukemia cell lines better than macrophages from non-leukemic mice. The grade of macrophage infiltration correlates in vivo with the survival of the mice. We found that the transcriptional repressor Growth factor independence 1 is crucial in the process of macrophage polarization, since its absence impedes macrophage polarization towards a leukemia supporting state and favors an anti-tumor state both in vitro and in vivo These results not only suggest that acute myeloid leukemia-associated macrophages play an important role in the progression of acute myeloid leukemia, but also implicate Growth factor independence 1 as a pivotal factor in macrophage polarization. These data may provide new insights and opportunities for novel therapies for acute myeloid leukemia.

Indexed as

AnimalsBone MarrowCell Line, TumorCell MovementDisease Models, AnimalDisease ProgressionDNA-Binding ProteinsHumansLeukemia, Myeloid, AcuteMacrophagesMiceMice, TransgenicSpleenTranscription FactorsDNA-Binding ProteinsGFI1 protein, humanTranscription Factors

Identifiers

PMID27390361
PMCPMC5046651
OpenAlexW2474232167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.